Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE- Pepsi, Select Comfort, Nokia, American Express

Thu, 18th Apr 2013 11:37

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s)

April 18 (Reuters) - Some U.S. stocks to watch on Thursday:

FUTURES SIGNAL HIGHER OPEN

Index futures pointed to a slightly higher open on WallStreet. Futures for the S&P 500, the Dow Jones andthe Nasdaq 100 were up 0.1 to 0.2 percent.

** PEPSICO INC, Wednesday close $78.85, up 1 pctpremarket

The maker of Pepsi sodas, Tropicana juices, Frito-Lay snacksand Quaker oatmeal reported better-than-expected first-quarterearnings, as price increases helped margins.

** NOKIA , Wednesday close $3.58, down 13pct premarket

A big fall in sales of the company's basic phonesovershadowed a stronger performance from its Lumia smartphonesin the first quarter, and it said it expected operating marginsto deteriorate.

Chief Executive Stephen Elop said tougher competition wasthe main reason behind the fall in sales of regular mobilephones.

** AMERICAN EXPRESS CO, Wednesday close $64.13, down1.5 pct after market

The credit card company's first-quarter revenue came inbelow analysts' expectations as cardmember spending growthremained muted.

** UNITEDHEALTH GROUP INC, Wednesday close $62.03

The nation's largest health insurer said its first-quarterprofit had fallen, in part because of lower government paymentsfor its private Medicare services and prescription plans forolder Americans.

** SELECT COMFORT CORP, Wednesday close $17.56,down 15 pct after market

The specialty mattress maker said it would revert to itsearlier marketing strategy after a shift in advertising reducedexposure of its products to already cautious customers and hitsales.

** ALLISON TRANSMISSION HOLDINGS INC, Wednesdayclose $21.16, up 9 pct after market

The maker of fully-automatic transmissions said late onWednesday that investment funds affiliated with Carlyle Group LP and Onex Corp would not proceed with a secondaryoffering of Allison Transmission's common stock due to marketconditions.

** SANDISK CORP, Wednesday close $55.72, up 3 pctpremarket

The company raised its forecast for revenue this year andsaid it expects higher prices for its NAND memory chips, whichare used in smartphones and tablets.

** EBAY INC, Wednesday close $56.10, down 3.6 pctpremarket

The e-commerce company gave a disappointing earningsforecast for the second quarter and said Europe was weak,pushing its shares lower in after-hours trade.

** ROPER INDUSTRIES INC, Wednesday close $120.54,

The diversified U.S. manufacturer said it would buyhealthcare services company Managed Health Care Associates Incfor $1 billion in an all-cash deal to expand its presence in thehealthcare market.

** THERAVANCE INC, Wednesday close $28.01, up 18pct after market

An advisory panel to the U.S. Food and Drug Administrationhas recommended that the agency approve an experimentaltreatment for smoking-related lung damage made by Britain'sGlaxoSmithKline Plc and Theravance.

** VALE SA ADR >, Wednesday close $15.82,up 2.5 pct after market

The top global iron ore miner's mega ship called at a portin eastern China this week, marking the first entry of thevessels since Beijing banned them in January2012.

** KEYCORP, Friday close $9.53

The bank reported first-quarter results which marginallybeat estimates helped by lower expenses and commercial loangrowth.

** ACCURAY INCORPORATED, Wednesday close $4.44

The radiation oncology company said it started on March 19voluntary recalls of two separate components from itsradiotheraphy product line CyberKnife. "The affected parts aremanufactured by third-party suppliers and are being removed fromthe system because they failed to meet the company'sspecifications and standards for quality," Accuray said in astatement.

** SINOVAC BIOTECH LTD, Wednesday close $4.13, up 2pct premarket

The pharmaceutical company said the Mexico health regulatorgranted marketing approval to its seasonal flu vaccine, namedAnflu. Sinovac said the certificate of commercial approval isvalid from April 1, 2013 to April 1, 2018. (Compiled by Aditi Shrivastava; Editing by Joyjeet Das)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.